A61K 31/285
Arsenic compounds
A61K31/285 (Arsenic compounds) appears on 62 US grants and 97 published applications in this corpus.
Search patents in A61K- Granted patents
- 62
- Published applications
- 97
- Assignees
- 48
- Inventors
- 172
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 4 |
| 2003 | 1 | 4 |
| 2004 | 3 | 18 |
| 2005 | 5 | 0 |
| 2006 | 1 | 2 |
| 2007 | 1 | 3 |
| 2008 | 0 | 2 |
| 2009 | 0 | 4 |
| 2010 | 0 | 1 |
| 2011 | 4 | 3 |
| 2012 | 5 | 5 |
| 2013 | 0 | 4 |
| 2014 | 3 | 2 |
| 2015 | 3 | 1 |
| 2016 | 3 | 2 |
| 2017 | 2 | 5 |
| 2018 | 2 | 3 |
| 2019 | 2 | 3 |
| 2020 | 2 | 6 |
| 2021 | 2 | 8 |
| 2022 | 7 | 2 |
| 2023 | 2 | 2 |
| 2024 | 1 | 6 |
| 2025 | 3 | 6 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of cancer using organoarsenicals16 Sep 2025US 12,414,931 B1The Florida International University Board of Trustees
- Arsinothricin and methods of treating infections using arsinothricin16 Sep 2025US 12,414,932 B2The Florida International University Board of Trustees
- Arsinothricin and methods of treating infections using arsinothricin20 May 2025US 12,303,485 B2The Florida International University Board of Trustees
- Arsinothricin as a multi-stage antimalarial23 Jan 2024US 11,877,996 B1The Florida International University Board of Trustees
- Anti-cancer agent comprising a tumour homing peptide having arsenic bonded to cysteine residues21 Nov 2023US 11,819,489 B2University of Wollongong
- Treatment of cancer using organoarsenicals8 Jan 2026US 2026/0007631 A1The Florida International University Board of Trustees
- Arsinothricin and methods of treating infections using arsinothricin25 Dec 2025US 2025/0387364 A1The Florida International University Board of Trustees
- Pharmaceutical preservation of cree activation with nitarsone for use in the treatment of neurodegenerative diseases25 Sep 2025US 2025/0295627 A1Leibniz-Institut fuer Neurobiologie
- Highly stable heavy metal-removing composition, use and dosage form thereof, and preparation method therefor25 Sep 2025US 2025/0295628 A1Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
- Arsinothricin and methods of treating infections using arsinothricin31 Jul 2025US 2025/0241885 A1The Florida International University Board of Trustees
Most cited
By later US patents
- Extended cycle multiphasic oral contraceptive method54US 8,063,030 B2Warner Chilcott Company, LLC · 2011
- Microbicidal composition containing potassium sodium tartrate35US 6,630,172 B22003
- Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol14US 6,770,304 B2Memorial Sloan Kettering Cancer Center · 2004
- Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol13US 6,723,351 B2Memorial Sloan Kettering Cancer Center · 2004
- Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation11US 6,312,686 B1Eisai Co., Ltd. · 2001